At a glance
- Originator Astra Arcus USA
- Class Antidepressants; Benzopyrans; Morpholines; Small molecules
- Mechanism of Action Serotonin 1B receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 23 Jan 2007 Discontinued - Preclinical for Depression in Sweden (unspecified route)
- 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed
- 09 Dec 1998 Preclinical development for Depression in Sweden (Unknown route)